Caxton Associates (New York)’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,928
| Closed | -$373K | – | 655 |
|
|
2023
Q1 | $373K | Sell |
5,928
-2,159
| -27% | -$136K | 0.06% | 308 |
|
|
2022
Q4 | $430K | Sell |
8,087
-8,034
| -50% | -$427K | 0.03% | 251 |
|
|
2022
Q3 | $904K | Buy |
16,121
+1,962
| +14% | +$110K | 0.12% | 125 |
|
|
2022
Q2 | $1.03M | Buy |
14,159
+11,163
| +373% | +$808K | 0.1% | 109 |
|
|
2022
Q1 | $238K | Hold |
2,996
| – | – | 0.02% | 380 |
|
|
2021
Q4 | $303K | Sell |
2,996
-390
| -12% | -$39.4K | 0.03% | 384 |
|
|
2021
Q3 | $312K | Hold |
3,386
| – | – | 0.03% | 282 |
|
|
2021
Q2 | $347K | Hold |
3,386
| – | – | 0.04% | 246 |
|
|
2021
Q1 | $330K | Buy |
+3,386
| New | +$330K | 0.03% | 230 |
|
|
2020
Q3 | – | Sell |
-3,742
| Closed | -$275K | – | 505 |
|
|
2020
Q2 | $275K | Buy |
+3,742
| New | +$275K | 0.02% | 272 |
|
|
2019
Q2 | – | Sell |
-3,443
| Closed | -$289K | – | 519 |
|
|
2019
Q1 | $289K | Buy |
+3,443
| New | +$289K | 0.04% | 254 |
|
|
2018
Q4 | – | Sell |
-2,699
| Closed | -$325K | – | 448 |
|
|
2018
Q3 | $325K | Sell |
2,699
-1,851
| -41% | -$223K | 0.02% | 267 |
|
|
2018
Q2 | $525K | Buy |
+4,550
| New | +$525K | 0.03% | 196 |
|